UMass Cancer Walk supports access to lifesaving clinical trials - UMass Chan Medical School
UMass Cancer Walk supports access to lifesaving clinical trials UMass Chan Medical School
🎗️
Онкология
🎗️Лента новостей
Онкология
T cell therapy shows promise in treating aggressive brain cancer
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form of immunotherapy that modifies an individual's own T cells (a type of immune cell) so they are…
Онкология
Онколог Бежанова заявила, что продуктов от рака не существует – ОСН - Общественная служба новостей
Онколог Бежанова заявила, что продуктов от рака не существует – ОСН Общественная служба новостей
Онкология
Онкология под прицелом: эксперты прогнозируют прорыв в лечении агрессивных опухолей - МедиаБрест
Онкология под прицелом: эксперты прогнозируют прорыв в лечении агрессивных опухолей МедиаБрест
Онкология
Experience builds confidence when it comes to speaking at meetings
Take a look at the Healio | OSN calendar page, and you will find more than three dozen meetings, symposia and summits that make up a year of ophthalmology gatherings. Whether they are one-room, single-day conferences, such as Clinical Trials at the Summit, or they take up full convention centers, such as the American…
Онкология
Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More - American Association for Cancer Research (AACR)
Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More American Association for Cancer Research (AACR)
Онкология
David Sebag-Montefiore: Exciting Milestone for the STAR-TREC Rectal Cancer Trial - Oncodaily
David Sebag-Montefiore: Exciting Milestone for the STAR-TREC Rectal Cancer Trial Oncodaily
🎗️
Онкология
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions - Alpha Tau Medical
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions Alpha Tau Medical
Онкология
Scientists in France pinpoint why STING pathway hasn't been harnessed for cancer therapy yet
Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer treatment. For years, scientists hoped an essential part of the innate immune system that detects foreign DNA in cellular cytoplasm—the STING pathway—could be harnessed for use in cancer immunotherapy.
Онкология
AIM ImmunoTech Secures U.S. Patent for Ampligen Combination with Pembrolizumab in Cancer Treatment - Quiver Quantitative
AIM ImmunoTech Secures U.S. Patent for Ampligen Combination with Pembrolizumab in Cancer Treatment Quiver Quantitative
🎗️
Онкология
Meet Tania Small, MD: A Force Behind The Fight For Cancer Research - essence.com
Meet Tania Small, MD: A Force Behind The Fight For Cancer Research essence.com
🎗️
Онкология
Meet Tania Small, MD: A Force Behind The Fight For Cancer Research - essence.com
Meet Tania Small, MD: A Force Behind The Fight For Cancer Research essence.com
Онкология
Онколог Чиж не ждёт 100% панацеи после прогноза о победе над 4 видами рака - Life.ru
Онколог Чиж не ждёт 100% панацеи после прогноза о победе над 4 видами рака Life.ru
Онкология
Онколог Чиж не ждёт 100% панацеи после прогноза о победе над 4 видами рака - Life.ru
Онколог Чиж не ждёт 100% панацеи после прогноза о победе над 4 видами рака Life.ru
🎗️
Онкология
Врач Ростовского онкоцентра рассказала о первых симптомах и методах профилактики рака кожи - газета Таганрогская правда
Врач Ростовского онкоцентра рассказала о первых симптомах и методах профилактики рака кожи газета Таганрогская правда